All News

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with activating mutations.

The FDA approved Imdelltra after a study showed longer survival compared with chemotherapy in advanced small cell lung cancer.

I never dreamed a stranger could teach me so much about cancer, life and living with gratitude but I'm so glad she did!

Dr. Jorge E. Cortes discussed the evolution of chronic myeloid leukemia treatment and emerging strategies aimed at improving outcomes and quality of life.

The oral therapy DPTX3186 received fast track status to help speed development of a potential new option for patients with gastric cancer.

Dr. Pamela L. Kunz sat down with CURE to discuss Neuroendocrine Tumors, or NETs, Awareness Month.

Dr. Benjamin Herzberg spotlighted some of the “weird and wacky” new ideas in the field of targeted therapies for the treatment of lung cancer.

A podcast from Triage Health simplifies health insurance and finances to help people facing serious illness make informed, confident decisions.

Dr. Adam J. Schoenfeld delivered an extensive overview of how cellular therapies are shaping the future of lung cancer care.

Many fail to recognize that estrogen is necessary to help your body and its parts work in concert with each other seamlessly.  

The FDA has granted fast track designation to ITM-94 as a diagnostic agent for the detection of the most common type of kidney cancer.

The FDA has approved Epkinly plus Revlimid and Rituxan for the treatment of patients with relapsed or refractory follicular lymphoma.

Steve Brown and Lisa Booth explain how AI platforms like CureWise offer clarity, reduce anxiety, and support informed decisions during the cancer journey.

I am thankful that a nurse navigator gave me continuity of compassionate care that helped me to heal from the inside out.

Young adults with newly diagnosed cancer may feel overwhelmed, but open communication with doctors and support groups can help them feel less alone.

Todd Kennedy, a multiple myeloma survivor, explains how switching from an hours-long IV infusion to a 3-minute Sub-Q injection changed his life.

A man nearing 76 reflects on aging, family, loss and living with cancer while finding gratitude in the holiday season.

For U.S. Marine Corps veteran and devout marathon runner Hank Donigan, not even a diagnosis of brain cancer could slow him down.

Patients with severe pancreatic cancer pain experienced consistent improvements in functionality and quality of life following targeted ablation therapy.

Dr. Joshua Sabai spoke with Dr. Chandler Park about the latest advances in kidney cancer, highlighting clinical trials that are shaping care for patients.

Learn about stage 2 vaginal cancer, including symptoms, diagnosis, treatment options, side effects and questions to discuss with your care team.

Stage 2 multiple myeloma can feel overwhelming. Learn what it means, treatment options, and key questions to discuss with your oncologist.

Breaking down the rare gastrointestinal cancer, from diagnosis to treatment.

This guide explains diagnosis, staging, treatment options, side effects and a patient’s metastatic experience with osteosarcoma.

A real-world study found TKIs were the most common therapy for adults with metastatic renal cell carcinoma after prior immune checkpoint inhibitor use.

A study at IKCS finds higher BMI after kidney cancer diagnosis improves survival, while significant weight loss predicts poorer outcomes.

LiveLung invites the Tampa area lung cancer community to its monthly educational meeting.

American Indian and Alaskan Native individuals face some of the highest kidney cancer burdens in the United States.